1.42% -0.11

4 D Molecular Therapeutics Inc (FDMT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der 4 D Molecular Therapeutics Inc-Aktie (FDMT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	500.00% 0.09	0.015	0.014	0.001	0.003
Operating Expenses	3.03% 61.27	59.47	53.63	56.12	51.13
Benefits Costs and Expenses	-	-	47.99	49.67	-
Costs And Expenses	3.03% 61.27	59.47	47.99	49.67	51.13
Depreciation and Amortization	8.15% 1.261	1.166	1.051	1.096	1.19
Operating Income/Loss	2.91% -61.19	-59.46	-53.62	-56.12	-51.13
Nonoperating Income/Loss	10.19% 4.309	4.798	5.649	6.446	7.289
Income/Loss From Continuing Operations Before Tax	100.16% 0.09	-54.66	-47.97	-49.67	0.003
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	4.06% -56.88	-54.66	-47.97	-49.67	-43.84
Net Income/Loss	4.06% -56.88	-54.66	-47.97	-49.67	-43.84
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.36% 56.13	55.93	55.74	0.566	55.55
Diluted Average Shares	0.36% 56.13	55.93	55.74	0.566	55.55
Basic Earnings Per Share	3.06% -1.01	-0.98	-0.86	-0.90	-0.79
Diluted Earnings Per Share	3.06% -1.01	-0.98	-0.86	-0.90	-0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%